SCHEMBL4900675

SCHEMBL4900675

N#Cc1ccccc1CC=CF

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.38
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
LMNA P02545 2/20 0.33
HPGD P15428 2/20 0.33
FFAR1 O14842 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CTSB P07858 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28348597 0.81 TSHR (0.42) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL15321939 0.77 KDM4E (0.42) ALDH1A1MAPTLMNAHPGDKDM4E
SCHEMBL5035207 0.76 CYP19A1 (0.42) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL28879999 0.76 CYP19A1 (0.42) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL2372208 0.76 TSHR (0.45) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL2162474 0.76 GABRA1 (0.42) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL15320510 0.75 NOS2 (0.42)
SCHEMBL25620334 0.74 CYP19A1 (0.41) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL8440818 0.74 ALDH1A1 (0.51) CYP19A1SMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL28553209 0.73 CYP19A1 (0.40) CYP19A1SMN1; SMN2ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405331-B2 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-07-29 US disclosed
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-07-27 US disclosed
EP-1500641-A1 HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same HBB, AFF4, AFF2 CYP19A1 1989/4885SMN1; SMN2 3356/4885ALDH1A1 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.